Tuesday, January 11, 2022 1:55:57 PM
flipper44,
Of course we don’t “KNOW” if the parties are deliberately keeping everything quiet because the process has to play out according to the rules without favoritism shown or there will be a legal challenge from the big money thugs crying foul all the while their influence keeps the foot dragging in place. But if, and this is a big BUT IF, the treatment is as we think, a breakthrough that has been waiting for regs and manufacturing to catch up, then the time is now for everything to come together. The science as we have noted over the years is golden. The push back from the status quo has been severe. We are and have been along for the ride and that ride keeps us from being able to “KNOW” until “the process” comes to an end which is when patients will “KNOW” and create immediate demand. It’s easy to point fingers at NWBO as they are out front. It’s those behind the scenes painting much of the picture though and they are the bigger problem that gets overlooked. Best wishes.
Of course we don’t “KNOW” if the parties are deliberately keeping everything quiet because the process has to play out according to the rules without favoritism shown or there will be a legal challenge from the big money thugs crying foul all the while their influence keeps the foot dragging in place. But if, and this is a big BUT IF, the treatment is as we think, a breakthrough that has been waiting for regs and manufacturing to catch up, then the time is now for everything to come together. The science as we have noted over the years is golden. The push back from the status quo has been severe. We are and have been along for the ride and that ride keeps us from being able to “KNOW” until “the process” comes to an end which is when patients will “KNOW” and create immediate demand. It’s easy to point fingers at NWBO as they are out front. It’s those behind the scenes painting much of the picture though and they are the bigger problem that gets overlooked. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
